- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 8.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 8.55M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 8.53M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $38M |
| Capex | Q1 2026 · Mar 31, 2026 | $7.4M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $600K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$116.8M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $18.4M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.18B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $169.8M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $9M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $15M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $113.1M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $161.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $30.3M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $6.5M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $588.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $77.6M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.13B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $255.7M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $937.5M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $297.5M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.22B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $333.4M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $7.19 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.39 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $7.27 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.39 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $162.6M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $28.9M |
| Net Income | Q1 2026 · Mar 31, 2026 | $61.5M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$3.4M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.8M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $25.6M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $155.6M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $54.5M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $252.2M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $49.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $407.8M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $103.9M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $44.1M |